Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Comments Comments
  •  (1)
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Four-in-One HIV Pill Enters Late-Stage Clinical Testing

April 13, 2010

"Gilead Sciences Inc. said Monday it started late stage clinical testing of its four-in-one 'Quad' HIV tablet," the Associated Press reports. The pill includes the drugs elvitegravir, cobicistat, and the two components of Truvada, emtricitabine and tenofovir (4/12). "The Phase III clinical program for the Quad includes two studies ... that will evaluate the Quad regimen versus a standard of care among" HIV-positive adults who have not yet started antiretroviral treatment, according to a Gilead press release (4/12).

Back to other news for April 2010


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Comments Comments
  •  (1)
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More Research on Stribild (Elvitegravir/Cobicistat/FTC/Tenofovir)

 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement